Table 4.
Differentially expressed genes in frontal vs. vertex scalp of responders after MTF 5% treatment. There were 40 differentially expressed transcripts in frontal scalp compared with vertex after MTF 5% treatment. Regional variations in gene expression changed after the treatment with MTF 5%.
| Gene | log2 (fold change) |
|---|---|
| COL6A6 | 0.52 |
| LOC100131796 | 0.49 |
| ACOT4 | 0.47 |
| LOC399898 | 0.47 |
| BIVM | 0.46 |
| AKR7L | 0.44 |
| BTN2A3P | 0.44 |
| CD274 | 0.43 |
| CIDEA | 0.43 |
| MIR331 | 0.43 |
| AP1S3 | 0.42 |
| ACE2 | 0.41 |
| SND1-IT1 | 0.41 |
| UPB1 | 0.41 |
| FABP5 | −0.41 |
| SNORA70D | −0.41 |
| KCNK10 | −0.42 |
| KRTAP1–1 | −0.43 |
| MMP7 | −0.43 |
| CNTNAP2 | −0.45 |
| KRTAP1–3 | −0.45 |
| CLEC1A | −0.46 |
| PGM2L1 | −0.47 |
| ERVFC1–1 | −0.48 |
| KRT82 | −0.49 |
| OR2T8 | −0.5 |
| ORM2 | −0.5 |
| KRT75 | −0.53 |
| OR10G3 | −0.53 |
| KRTAP3–1 | −0.57 |
| KRT31 | −0.58 |
| KRT33B | −0.58 |
| KRT85 | −0.59 |
| KRT83 | −0.63 |
| CST1 | −0.64 |
| KRT39 | −0.65 |
| HEPHL1 | −0.66 |
| SPP1 | −0.67 |
| LYRM9 | −0.72 |
| FAM26D | −0.74 |